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SUMMARY 
 
1. We have examined whether modulation of the polyamine biosynthetic pathway, through 
inhibition by α-difluoromethylornithine (DFMO) of the rate limiting enzyme, ornithine 
decarboxylase (ODC), modulates NO synthesis in J774 macrophages.  
 
2.  DFMO potentiated LPS-stimulated nitrite production in both a concentration- and time-
dependent manner, increasing nitrite levels by 48 ± 5% at 10 mM. This effect was observed in 
cells pre-treated with DFMO for 24 h prior to stimulation with LPS. Addition of DFMO 12 h 
after LPS failed to potentiate LPS-induced nitrite production.   
 
3. Supplementation of the culture medium with horse serum (10 %) in place of foetal calf serum 
(10 %) caused no significant change in either LPS-induced nitrite production or in the ability of 
DFMO (10 mM) to potentiate LPS-induced NO synthesis.  
 
4. Metabolism of L-[3H]arginine to L-[3H]citrulline by partially purified inducible nitric oxide 
synthase (iNOS) was not significantly altered by either DFMO (1-10 mM) or by putrescine 
(0.001-1mM), spermidine (0.001-1 mM) or spermine (0.001-1 mM). iNOS activity was also 
unaffected by 1 mM EGTA but was markedly attenuated (70 ± 0.07%) by L-NMMA (100 μM). 
 
5. Pre-incubation of cells with DFMO (10 mM; 24 h) prior to activation with LPS resulted in 
enhanced (~2-fold) iNOS protein expression.  
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6. These results show that DFMO potentiates LPS-induced nitrite production in the murine 
macrophage cell line J774. Since the only known mechanism of action of DFMO is inhibition of 
ODC, and thus polyamine biosynthesis, we conclude that expression of iNOS can be critically 
regulated by endogenous polyamines.   
 
 
 
Key Words: Macrophages; Bacterial lipopolysaccharide; Nitric oxide; Inducible nitric oxide 
synthase; Polyamines; α-Difluoromethylornithine; Ornithine Decarboxylase. 
 
 
 
Abbreviations: AEBSF: 4-(2-aminoethyl)-benzenesufonylfluoride; BSA: bovine serum 
albumin; DFMO; α-difluoromethylornithine; DMEM: Dulbecco's Modified Eagle's Medium;  
EGTA: ethylene glycol-bis(ß-aminoethyl ether) N,N,N',N'-tetraacetic acid; FAD: flavin adenine 
dinucleotide; iNOS: inducible nitric oxide synthase; LPS: bacterial lipopolysaccharide; mM: 
millimolar; MTT: (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide); NADPH: 
nicotinamide adenine dinucleotide phosphate; NO nitric oxide; L-NMMA: NG-monomethyl-L-
arginine; ODC: ornithine decarboxylase; SDS: sodium dodecyl sulfate; μM: micromolar 
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INTRODUCTION 
 
Polyamines are physiological cellular constituents essential for cell growth and differentiation, 
and regulate a multitude of cellular functions (Morgan, 1987a, Jänne et al., 1991). In mammalian 
cells, the naturally occurring polyamines putrescine, spermidine and spermine are synthesised 
from the cationic amino acid L-arginine which is metabolised by arginase to yield ornithine and 
subsequently polyamines via the rate-limiting enzyme ornithine decarboxylase (ODC; Morgan, 
1987a; McCann & Pegg, 1992). This enzyme, like the inducible nitric oxide synthase (iNOS), is 
induced by proinflammatory cytokines and bacterial lipopolysaccharide (LPS) resulting in 
enhanced enzyme activity and thus polyamine synthesis (Tjandrawinata et al. 1994). While this 
would have important implications in terms of cell growth and proliferation it is not clear what 
effects this might have on the inducible nitric oxide synthase pathway, which also utilizes L-
arginine for the synthesis of nitric oxide (NO).  
 
Recently, exogenous polyamines have been shown to inhibit NO production in LPS-activated 
J774 cells (Szabó et al., 1994a, 1994b) and by isolated neuronal NO synthase (Hu et al., 1994). 
These effects however required relatively high concentrations of polyamines compared to those 
found in plasma and in intact cells (Morgan 1990), and appear to be due to accumulation of 
aldehyde metabolites resulting from polyamine oxidation by an amine oxidase present in calf 
serum (Szabó et al., 1994a). The question of whether there is any interaction between the 
polyamine and iNOS pathways or whether endogenous polyamines regulate iNOS expression 
and/or activity still remains to be established.  
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In this study we have examined the effects of endogenous polyamines on the inducible L-
arginine-NO pathway by examining whether α-difluoromethylornithine (DFMO), a potent and 
selective inhibitor of ODC (McCann & Pegg, 1992), regulates LPS-induced NOS expression or 
NO production in the murine macrophage cell line J774. The dependency of the actions of 
DFMO on serum amine oxidases was investigated by examining its effects in cells cultured in 
Dulbecco's Modified Eagle's Medium (DMEM) containing either foetal calf serum or horse 
serum, the latter having low levels of amine oxidases (Blaschko, 1962). 
 
METHODS 
Cell culture 
The murine macrophage cell line J774 was maintained in continuous culture in DMEM 
supplemented with NaHCO3 (42 mM), penicillin (100 units ml-1) and streptomycin (100 units ml-
1), 2 mM glutamine and 10% foetal calf serum.  Monolayers of cells were routinely harvested by 
gentle scraping with a Teflon cell-scraper, diluted 1:10 in fresh medium and cultured to 
confluency at 37oC. 
 
Analysis of  nitrite production  
Prior to each experiment, cells were harvested and plated at a seeding density of 105 cells per 
well in 96-well microtiter plates. Confluent monolayers of cells were activated with  0.1 μg ml-1 
LPS (Eschericia coli, serotype 0111:B4) alone or in combination with DFMO (1-20 mM). In 
these studies DFMO was either added simultaneously with LPS and/or polyamines, or pre-
incubated with cells for 24 h or 48 h prior to stimulation, replacing the culture medium with 
fresh DMEM plus DFMO every 24 h. In another series of experiments, DFMO (10 mM) was 
added to the culture medium at 3h , 6 h and 12 h after LPS.  NO production was determined 24 h 
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after LPS-activation of cells by measuring accumulated nitrite levels in the culture medium as 
previously described (Cirino et al., 1996). Briefly, 50 μl of sample was incubated with 0.1 U 
nitrate reductase for 15 min at 37oC in the presence of FAD (5 nmoles) and NADPH (50 
nmoles). This was followed by a further 5 min incubation of samples with lactate dehydrogenase 
(10 U) and sodium pyruvate (10 μmoles).  Total nitrite was subsequently determined by the 
Griess reaction (Green et al, 1982) and expressed as nmoles μg protein-1 24 h-1.  Cell protein was 
measured for each well using Brilliant Blue G (Bradford, 1976). Briefly, culture medium was 
removed from well, cells washed 3 times with 200 μl phosphate buffered saline and incubated at 
room temperature for 30 min with 200 μl of Brilliant Blue G reagent (0.01 % w/v Coomassie 
Brilliant Blue G-250 , 5 % w/v ethanol and 10 % orthophosphoric acid. Absorbance was 
measured at 620 nm using a Multiskan plate reader (Flow, UK) and the amount of protein per 
well determined by reference to a standard curve constructed using bovine serum albumin as 
standards. 
 
Western blot analysis of iNOS expression  
Confluent monolayers of J774 cells in 24-well culture plates (5 x 105 cells per well) were pre-
incubated with either DMEM alone or with DMEM containing DFMO (10 mM). The medium 
was removed after 24 h and replaced with fresh DMEM or with DMEM containing LPS (0.1 μg 
ml-1) and/or DFMO (10 mM). Incubations were terminated after 24 h by rapid aspiration of the 
cell supernatant followed by washing with ice-cold phosphate-buffered saline (140 mM NaCl, 
2.7 mM KCl, 8.1 mM Na2HPO4, 1.5 mM KH2PO4, pH 7.4). Cells were lysed in buffer 
containing 63.5 mM Tris-HCl (pH 6.8), 10% glycerol, 2% SDS, 5% ß-mercaptoethanol, 1 mM 
4-(2-aminoethyl)-benzenesufonylfluoride (AEBSF) and 50 mg ml-1 leupeptin. Samples were 
then probed for iNOS protein levels as described previously (Cirino et al., 1996). Briefly, lysates 
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(20 μg protein per lane) were separated by SDS-PAGE electrophoresis on 8 % polyacrylamide 
gel and transferred for 3 h at 0.8 mA cm2 onto 0.2 mm nitrocellulose membrane (Anderman and 
Co., Kingston-upon-Thames, Surrey, U.K.). Membranes were blocked for 2 hours at room 
temperature in 100 mM NaCl, 10 mM Tris, 0.1% (v/v) Tween-20, pH 7.4 (STT) containing 3% 
(w/v) BSA and subsequently probed overnight with mouse monoclonal anti-iNOS antibody 
(1/2500 dilution in STT containing 0.2% (w/v) BSA). Blots were washed with STT (6 x 5 min) 
and incubated with horseradish peroxidase-conjugated rabbit anti-mouse IgG (1/10,000) for 1 
hour at room temperature. Following further washing (6 x 5 min) in STT, immunoreactive bands 
were visualised using the ECL detection System (Amersham Life Sciences, Little Chalfont, UK). 
Protein bands were quantified by scanning densitometry (UVP E.A.S.Y. Plus Enhanced Analysis 
System; Ultra-Violet Products Ltd, Cambridge, UK) and the data expressed as a percentage of 
the value obtained for samples from cells treated with LPS alone. 
 
Analysis of isolated iNOS activity 
J774 macrophages (9.5 x 106 cells) in 75 cm2 culture flasks were activated with LPS (1 μg ml-1) 
for 18 h and harvested with a cell scraper into 1 ml of homogenization buffer containing 50 mM 
Tris-HCl, 320 mM sucrose, 1 mM EDTA, 1 mM dithiothreitol, 10 μg ml-1 leupeptin, 10 μg ml-1 
soybean trypsin inhibitor and 2 μg ml-1 aprotinin. Cells were lysed by freezing the suspension at 
   -70oC and thawing at 37oC three times. The lysate was then centrifuged at 10,000 g for 60 min 
at 4oC. Activity of the partially purified enzyme was determined by monitoring the conversion of 
L-[3H]arginine to L-[3H]citrulline in the absence and presence of NG-monomethyl-L-arginine (L-
NMMA; 100μM), ethylene glycol-bis(ß-aminoethyl ether) N,N,N',N'-tetraacetic acid (EGTA; 1 
mM), DFMO (1-10 μM), putrescine (0.001-1 mM), spermidine (0.001-1 mM) or spermine 
(0.001-1 mM) as described by Brown et al. (1992). Briefly, 20 μl of 10,000 g supernatant plus 
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compound of choice was added to 100 μl of assay buffer consisting of 50 mM KH2PO4, 1 mM 
MgCl2, 0.2 mM CaCl2, 50 mM valine, 1 mM dithiothreitol, 100 μM NADPH, 1 mM L-citrulline, 
20 μM (0.5 μCi ml-1) L-[3H]arginine. The reactions were incubated for 20 min at 37oC and L-
[3H]citrulline separated from L-[3H]arginine by adding 1 ml of a 1:1 suspension of Dowex (AG 
50W-8) in water to each sample. The supernatant was transferred into ß-vials and radioactivity 
measured by liquid scintillation counting. 
 
Assessment of cell viability 
Cell viability was determined under different experimental conditions by monitoring 
mitochondrial-dependent reduction of (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium 
bromide) (MTT) to formazan as described by Mossmann (1983). Briefly, after each experimental 
protocol, cells in 96-well plates were incubated with MTT (0.5 mg ml-1) for 4 h at 37oC. An 
equal volume of 10% SDS in 0.01 M HCl was then added to all wells and incubated for a further 
3 h. Absorbance was read at 560 nm using a Multiskan II plate reader (Titertek). Readings 
obtained from treated cells were compared to controls.  
 
Materials 
Tissue culture reagents, bacterial lipopolysaccharide from Escherichia coli (serotype 0111:B4), 
polyamines, nitrate reductase, NADPH, FAD, lactate dehydrogenase, sodium pyruvate, MTT, 
EGTA and Dowex (AG 50W-8) were obtained from Sigma (Poole, U.K.). L-NMMA was 
purchased from Alexis Corporation (Nottingham, UK). Monoclonal antibody for inducible nitric 
oxide synthase was from Affiniti Research Products Ltd (Nottingham, U.K.). Other chemicals 
were from Sigma or BDH and of the highest analytical grade obtainable. 
Difluoromethylornithine was a gift from Marion Merrell Dow, Cincinnati, OH. 
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Statistics 
All values are means ± s.e.m. of measurements in at least three different experiments with 5 
replicates in each. Statistical analyses were performed using a parametric multiple means 
comparison Peritz ‘f’ test (Harper, 1984) which was validated using the Longley set of ‘stiff’ 
data (Lachenbruch, 1983; Wilson, 1983). The overall confidence level was set at 99% (P<0.01). 
Statistical analyses were performed on raw data. Normalisation of the data (as percentage of 
controls) did not alter the significance levels (p-values) of differences found.  
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RESULTS 
Effects of DFMO on LPS-stimulated nitrite production 
Incubation of J774 cells with LPS (0.1 μg ml-1) stimulated nitric oxide production, elevating 
nitrite levels from a basal value of 0.19 ± 0.01 to 1.35 ± 0.14 nmole μg protein-1 24 h-1. This was 
further potentiated in a concentration-dependent manner by DFMO which produced maximal 
effects at 10 mM, increasing LPS-stimulated nitrite levels by a further 48 ± 5 % (Fig 1). This 
response is not dependent on serum type since at 10 mM DFMO enhanced LPS-induced nitrite 
production equally in the presence of either foetal calf (10 %) or horse serum  (10 %) (Table 1). 
 
Potentiation of nitrite release by DFMO was not affected by exogenous putrescine (10-100 μM) 
or spermidine (10-100μM) in the presence of calf serum but was markedly attenuated by non-
physiological concentrations of spermine which at 100μM reduced responses to both LPS and 
LPS plus DFMO by 76 ± 12 % and 64 ± 9 % respectively. Physiological concentrations of 
spermine (10 μM) were without effect (data not shown). 
 
Although addition of DFMO simultaneously with or for 48 h prior to LPS enhanced nitrite 
levels, the increases observed were relatively less compared to that after 24 h pre-treatment (Fig 
2). Similarly, DFMO was less effective in potentiating nitrite production when applied to the 
culture medium upto 12 h after LPS (Table 2). Incubation of cells for up to 48 h with DFMO (10 
mM) alone failed to enhance nitrite accumulation above basal values. Over this prolonged period 
of incubation, mitochondrial reduction of MTT to formazan was not significantly altered, 
suggesting that DFMO does not cause any adverse effects to J774 cells even when applied at 
high concentration and for relatively long periods (data not shown).  
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Effects of DFMO on isolated iNOS activity 
In order to ascertain whether DFMO or polyamines altered the activity of iNOS once induced, 
experiments were carried out exploring the direct effects of DFMO (1-10 mM) on enzyme 
activity by monitoring the conversion of L-[3H]arginine to citrulline using lysates from LPS-
activated J774 cells. Unstimulated J774 cells had no detectable NOS activity. Following 
activation with LPS (1 μg ml-1) total NOS activity was significantly elevated (159 ± 11.4 pmoles 
L-[3H]citrulline mg protein-1 20 min-1) and was unaffected by removal of calcium from the 
reaction buffer using 1 mM EGTA. L-NMMA, (100 µM) inhibited L-[3H]citrulline production 
by 70%. In contrast neither DFMO (1-10 mM) nor putrescine (0.001-1 mM), spermidine (0.001-
1 mM) or spermine (0.001-1 mM) caused any significant change in the production of L-
[3H]citrulline (Table 3). 
 
Western blot analysis 
To determine whether the potentiation caused by DFMO was due to enhanced iNOS expression, 
Western blot analysis was carried out on whole cell lysates using a monoclonal antibody for 
murine iNOS. In these studies, the antibody recognised a single 130 kDa protein band in lysates 
from LPS-activated (0.1 μg ml-1; 18 h) cells but not from cells incubated either with DMEM 
alone or DMEM plus DFMO (10 mM). Moreover, iNOS expression was increased by 92 ± 11% 
(n=4) in cells pre-incubated with DFMO (10 mM) for 24 h prior to activation with LPS. A 
representative blot from these experiments is shown in Fig 3.  
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DISCUSSION  
The present study demonstrates that pre-incubation of J774 macrophages with DFMO potentates 
LPS-induced nitrite production. This effect is both time- and concentration-dependent and 
appears to involve regulation of iNOS expression at the molecular level resulting in increased 
enzyme protein expression and thus NO production. The maximal response was obtained 
following 24 h pretreatment of cells with 10 mM DFMO prior to activation with LPS. Although 
addition of DFMO simultaneously with LPS also enhanced accumulated nitrite levels, the 
potentation was relatively less compared to responses produced after 24 h pre-incubation. 
Furthermore, when added 12 h after LPS, DFMO failed to potentate LPS-induced nitrite 
production. These findings suggest that the effects of DFMO are not mediated directly on iNOS 
but rather at certain upstream events associated with induction of the enzyme.  
 
Induction of iNOS is a time dependent process requiring de novo protein synthesis. Enzyme 
expression is detected ~6 h after activation of cells, reaching a maximum at 12 h and is 
maintained over a period of 24-48 h (Assreuy et al., 1993). Thus the fact that addition of DFMO 
12 h post LPS failed to alter LPS-induced nitrite production strongly suggests that DFMO has no 
effect on iNOS activity once induced. This was confirmed in experiments carried out to examine 
the direct effect of DFMO on the partially purified enzyme isolated from LPS activated J774 
cells. In these studies DFMO did not alter the metabolism of [3H]arginine to citrulline by iNOS. 
In contrast, Western blot analysis of lysates obtained from cells activated in the presence of LPS 
alone and in combination with DFMO showed LPS-induced iNOS protein expression was 
significantly augmented in the presence of DFMO, demonstrating increased iNOS gene 
transcription and/or mRNA stability. 
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The only known action of DFMO is irreversible inhibition of ODC by covalently binding to the 
enzyme (Poulin et al., 1992;  McCann & Pegg, 1992). It is therefore reasonable to suggest that 
the novel actions observed in our study results from inhibition by DFMO of ODC with a 
consequential depletion of intracellular polyamines, especially putrescine and spermidine which 
are sequentially metabolized to spermine. These polyamines can be depleted by 60-70% at 24 h 
and to below detectable levels 48 h after exposure to DFMO (Mamont et al, 1978). Under these 
conditions, the constraint on iNOS expression exerted by endogenous polyamines is overcome 
resulting in over expression of iNOS protein.  In this regard it is interesting that exposure of 
RAW 264 macrophages to LPS and interferon-gamma results in enhanced ODC activity and 
polyamine synthesis. Induction of ODC occurs relatively rapidly with maximal enzyme activity 
peaking at 4 h. Moreover  this response precedes the induction of iNOS (Tjandrawinata et al., 
1994). Our current findings are therefore consistent with the suggestion that the early 
upregulation in ODC activity and subsequent increase in endogenous polyamines modulate the 
induction of iNOS by down regulating iNOS protein expression. This coercion is presumably 
overcome following inhibition of ODC by DFMO.  
 
In an attempt to further validate this hypothesis additional experiments were carried out 
examining the effects of exogenous polyamines on DFMO-potentiated nitrite release.  The 
results obtained suggest that spermine may be the critical regulatory polyamine since 
accumulated nitrite levels were markedly attenuated by spermine and not by spermidine or 
putrescine. However,  inhibitory responses were only observed at relatively high non-
physiological concentrations, thus questioning the selectivity of these effects. At lower 
concentrations spermine failed to alter either LPS-induced or DFMO potentiated nitrite 
production. This may reflect the highly positively charged nature of spermine which, once inside 
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the cell,  may become predominantly bound to intracellular components. The free intracellular 
concentration may thus be very low, especially under conditions in which synthesis is inhibited 
and supply is dependent on influx from low extracellular pools. 
The ability of spermine to inhibit nitrite synthesis is supportive of other reports which have 
shown that exogenous polyamines, taken up by specific transport mechanisms (Seiler & 
Dezeure, 1990; Seiler et al. 1996), inhibit NO synthesis by endothelial constitutive NOS (Galea 
et al., 1996), neuronal constitutive NOS (Hu et al., 1994; Galea et al., 1996) or macrophage 
inducible NOS (Sazbò et al., 1994a, 1994b). However, the relatively high concentrations 
required questions the selectivity and relevance of such effects since the inhibitions observed 
may simply reflect non-specific cytotoxic action of spermine metabolites generated by serum 
amine oxidases. This suggestion is supported by a recent report by Sazbò et al.  (1994a) in which 
inhibition of iNOS protein expression was found to be critically dependent on the metabolism of 
spermine to toxic aldehydes by amine oxidases present in foetal calf serum.  
 
In our studies, modulation of LPS-induced nitrite production by DFMO was not dependent on 
extracellular amine oxidases in that the effects observed were similar in both foetal calf and 
horse serum, although the latter has much lower levels of amine oxidases (Blaschko, 1962). 
Moreover, unlike exogenous metabolism, the acetylation of primary amino groups is the first 
step in the intracellular metabolism of polyamines (Casero & Pegg, 1993). This is followed by 
oxidation by an intracellular polyamine oxidase (Morgan, 1989), resulting in the production of 
acetylated aldehydes which are relatively non-cytotoxic (Morgan, 1987b). Thus the effects of 
endogenous polyamines, acting intracellularly, are likely to be more specific.  
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We are aware that the data presented here differ from our previous preliminary findings that 
DFMO could apparently inhibit LPS-induced NO synthesis (Morgan, 1994). This discrepancy 
appears to be related to the protocol of induction. In the present study culture medium was 
replaced every 24 h with fresh medium containing DFMO and/or LPS as appropriate. In contrast, 
in our previous study cells were incubated with DFMO for periods of up to 48 h followed by 
activation with LPS without replenishing the incubation medium. This procedure is likely to 
have resulted in the progressive depletion of DFMO, thus overcoming its inhibitory actions on 
ODC. This hypothesis is supported by the fact that (i) expression of ODC is repressed by 
polyamines (Hayashi, 1989), (ii) depletion of endogenous polyamine pools by DFMO enhances 
ODC gene transcription (Alhonen-Hongisto et al., 1985, 1987; Leinonen et al., 1987) and (iii) 
ODC has a short half-life (under 30 min) which is further reduced (to ~3 min) in the presence of 
DFMO (McCann & Pegg, 1992). Thus the rapid turnover together with the de-repression and 
over expression of ODC may inevitably lead to the depletion of DFMO. Frequent replenishment 
of culture medium with DFMO may therefore be required to overcome its depletion and 
maintain its inhibitory actions (Pegg, 1986).  
 
We conclude that DFMO depletion of endogenous polyamine pools regulates iNOS expression, 
modulating cellular signalling mechanisms associated with the induction of iNOS protein. These 
findings may have significant implications for the potential application of DFMO and could 
account, at least in part, for the cytostatic and indeed antitumour properties of this compound. 
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Figure 1. Concentration-dependent potentiation of LPS-induced nitrite production in J774 
macrophages by α-difluoromethylornithine (DFMO). Cells cultured in DMEM containing 10% 
foetal calf serum were incubated with DFMO for 24 h prior to activation with LPS (0.1 µg ml-1). 
Accumulated nitrite in the culture medium was determined after a further 24 h by the Griess 
reaction as described in the methods. Results are expressed as % of the LPS response and values 
are the mean ± s.e. mean of 3 independent experiments with 5 replicates in each. All values in 
the DFMO treated group are significantly different at p<0.01 from the LPS control. 
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Figure 2. Time-dependent potentiation of LPS-induced nitrite production in J774 macrophages 
by α-difluoromethylornithine (DFMO). Cells cultured in DMEM containing 10% foetal calf 
serum were preincubated with DFMO (10 mM) for 0h, 24 h or 48h prior to activation with LPS 
(0.1 µg ml-1). Accumulated nitrite in the culture medium was determined by the Griess reaction 
after a further 24 h incubation period. Results are expressed as % of the LPS response and values 
are the mean ± s.e. mean of 5 independent experiments with 5 replicates in each. All values in 
the DFMO treated group are significantly different at p<0.01 from the LPS control. 
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Figure 3. Western blot analysis of inducible nitric oxide synthase (iNOS) expression in J774 
macrophages. Expression of iNOS protein in whole cell lysates were detected as described in the 
methods using a selective monoclonal anti-iNOS antibody. Lysates were obtained from control 
cells, cells incubated with α-difluoromethylornithine (DFMO, 10 mM) alone for 24 h following 
24 h pre-treatment,  cells stimulated with LPS (0.1 µg ml-1, 24 h) alone, and cells incubated with 
LPS (0.1 µg ml-1, 24) and DFMO (10 mM) following 24 h pre-incubation with DFMO (10 mM).  
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Table 1: Effects of foetal calf or horse serum on potentation of LPS-induced nitrite production 
by α-difluoromethylornithine (DFMO). 
 
 __________________________________________________________ 
  Conditions      Nitrite Levels 
        (nmoles μg protein-1 24 h-1) 
  __________________________________________________________ 
 
  cells cultured in 10% foetal calf serum: 
  Control       0.22 ± 0.017 
  DFMO (10 mM)      0.25 ± 0.021 
  LPS (0.1 μg ml-1)      1.07 ± 0.11 
  LPS (0.1 μg ml-1) + DFMO (10 mM)    1.59 ± 0.13* 
 
  cells cultured in 10% horse serum: 
  Control       0.18 ± 0.02 
  DFMO (10 mM)      0.15 ± 0.02 
  LPS (0.1 μg ml-1)      0.98 ± 0.06 
  LPS (0.1 μg ml-1) + DFMO (10 mM)    1.47 ± 0.11* 
  _________________________________________________________ 
 
Cells cultured in DMEM containing either foetal calf or horse serum were pre-treated with 
DFMO for 24 h and then incubated with fresh medium containing LPS and/or DFMO. 
Accumulated nitrite in the culture medium was determined after a further 24 h incubation period 
by the Griess reaction. Results are expressed as the mean ± s.e. mean of 3 separate experiments 
with 5 replicates in each. *denotes p<0.01 compared to responses obtained with LPS alone.  
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Table 2: Time-dependent regulation of LPS-induced nitrite production by of α-difluoromethyl- 
ornithine (DFMO) 
 
 __________________________________________________________ 
  Conditions      Nitrite Levels 
        (nmoles μg protein-1 24 h-1) 
  __________________________________________________________ 
 
  Control       0.23 ± 0.02 
  LPS (0.1 μg ml-1)      1.04 ± 0.11 
  LPS (0.1 μg ml-1)        1.35 ± 0.08* 
  + DFMO (10 mM), 3 h post LPS   
  LPS (0.1 μg ml-1)        1.16 ± 0.11 
  + DFMO (10 mM), 6 h post LPS 
    
LPS (0.1 μg ml-1)        0.96 ± 0.09 
+ DFMO (10 mM), 12 h post LPS  
 _________________________________________________________ 
 
 
Cells cultured in DMEM containing 10% foetal calf serum were activated with LPS in the 
absence (LPS) and presence of DFMO added at 3 h, 6 h and 12 h after LPS. Accumulated nitrite 
in the culture medium was determined by the Griess reaction 24 h after addition of LPS. Results 
are expressed as the mean ± s.e. mean of at least 3 separate experiments with 5 replicates in each. 
* denotes p<0.01 compared to responses obtained with LPS alone.  
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Table 3. Effects of α-difluoromethylornithine (DFMO), putrescine, spermidine and spermine on 
isolated inducible nitric oxide synthase (iNOS) activity. 
  ________________________________________________ 
  Conditions   L-[H3]citrulline Production  
       (% of control) 
  ________________________________________________ 
 
  Control    100 ± 3.3 
 + EGTA,    1 mM  103 ± 2.3 
  + L-NMMA,   100 μM    30 ± 2.7 
  + DFMO            1 mM  103 ± 3.5 
               2.5 mM  101 ± 6.9 
               5.0 mM  104 ± 5.5 
             10.0 mM  106 ± 3.4 
 
  + Putrescin     1 μM  113 ± 6.8   
                10 μM    90 ± 7.1 
               100 μM  112 ± 5.7 
            1000 μM  111 ± 6.9        
  
 + Spermidine      1 μM    98 ± 7.4  
                10 μM  101 ± 3.9 
               100 μM  108 ± 5.2 
             1000 μM  111 ± 6.7        
   
  + Spermine         1 μM  102 ± 5.6 
                10 μM    96 ± 6.6 
               100 μM  101 ± 6.3 
           1000 μM    91 ± 7.2 
________________________________________________ 
 
Production of  L-[H3]citrulline from L-[H3]arginine was determined as described in methods and 
expressed as % of that produced by enzyme in the absence of other compounds. Values obtained 
for polyamines are the mean of 6 replicates in 2 independent experiments with 3 replicates in 
each. All other values are the mean of 3 independent experiments with 3 replicates in each.
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